Tag: Teva

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

Stuart Mitchell

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a partnership with actor, comedian and advocate, Will Forte, to increase awareness of Huntington’s disease (HD). HD, a rare, progressive neurological disorder, affects more than 41,000 people in the U.S. and causes cognitive, behavioral and physical challenges, including HD chorea, which are involuntary movements that often impact daily life.1,3 As Teva’s new Honestly HD ambassador, Will is sharing his own family’s story with HD to help connect people navigating the disease with educational resources…

Read More

Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

Stuart Mitchell

Teva Pharmaceutical Industries Ltd. have published its 2024 Healthy Future Report, sharing actions to advance its sustainability strategy. Teva achieved or surpassed many of its targets, some ahead of schedule. This includes targets tied to sustainable finance instruments, which directly connect its progress in increasing access to medicines and minimizing environmental impact to the Company’s financial success. Healthy Future is focused on topics most relevant to Teva’s business, supporting the Company in advancing its purpose—we are all in for better health—and enhancing its resilience. Healthy PeopleTeva launched two new access…

Read More

Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets

Stuart Mitchell

Teva Pharmaceutical Industries Ltd. announced ambitious commitments to address two of today’s greatest global crises—access to medicines and climate change—tied to its recently issued $5 billion sustainability-linked bond. The bond is linked to three targets, including a 25% reduction in Scope 1 and 2 greenhouse gas (GHG) emissions and a 150% increase in access to essential medicines for patients in low- and middle-income countries (LMICs) by the end of 2025. “A key part of our environmental, social and governance (ESG) efforts is helping the world in ways we’re uniquely positioned…

Read More

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Stuart Mitchell

Teva Pharmaceutical Industries Ltd. has announced long-term environmental sustainability commitments and targets to provide direction and drive action in this area. Our new goals are part of Teva’s commitment to Environmental, Social and Governance (ESG) measurement, a key focus area for the business. ESG details how we achieve our business goals, underscores non-financial performance, and is considered critical to our long-term sustainability and success. These environmental sustainability commitments are aligned to three areas of focus that were identified during the company’s recently completed ESG materiality analysis, which informed the development…

Read More